STOCK TITAN

MiniMed Group (MMED) director Sandstrom files initial Form 3 ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

MiniMed Group, Inc. director Brian Sandstrom filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing lists him as a director of MiniMed Group but does not report any insider stock transactions.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sandstrom Brian

(Last) (First) (Middle)
C/O 18000 DEVONSHIRE STREET

(Street)
NORTHRIDGE CA 91325

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/05/2026
3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/ Brian Sandstrom 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the MiniMed Group (MMED) Form 3 filing show?

The Form 3 filing shows that Brian Sandstrom is a director of MiniMed Group, Inc.. It is an initial statement of beneficial ownership and does not report any insider stock transactions in this filing.

Who is the reporting person in MiniMed Group (MMED) Form 3?

The reporting person is Brian Sandstrom, identified as a director of MiniMed Group, Inc.. This status means he is considered an insider and must report his beneficial ownership and future transactions in company securities.

Does the MiniMed Group (MMED) Form 3 show any insider trades?

No insider trades are reported in this Form 3. The transaction summary shows zero buys, zero sells, and no derivative exercises, indicating this filing only establishes insider status without listing transactions.

What is the purpose of a Form 3 for MiniMed Group (MMED) insiders?

Form 3 serves as an initial beneficial ownership statement when someone becomes an insider of MiniMed Group, Inc.. It provides a baseline for future Form 4 and Form 5 reports of trades and other changes in ownership.

Is there any information about derivative securities in the MMED Form 3?

The Form 3 derivative summary for MiniMed Group, Inc. shows no derivative positions or derivative transactions. This indicates no options, warrants, or similar instruments are reported in this particular filing excerpt.